Which has stronger earnings and valuation, HNGE or DGX?

Quest Diagnostics has higher revenue and earnings than Hinge Health. Quest Diagnostics is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hinge Health $587.86M 13.49 -$528.26M $1.28 76.78 Quest Diagnostics $11.04B 2.28 $992M $9.42 24.23

Does the media refer more to HNGE or DGX?

In the previous week, Hinge Health had 3 more articles in the media than Quest Diagnostics. MarketBeat recorded 10 mentions for Hinge Health and 7 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.61 beat Hinge Health's score of 0.55 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, LH or HNGE?

Labcorp has higher revenue and earnings than Hinge Health. Labcorp is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Labcorp $13.95B 1.81 $876.50M $12.09 25.78 Hinge Health $587.86M 13.49 -$528.26M $1.28 76.78

Is LH or HNGE more profitable?

Hinge Health has a net margin of 15.15% compared to Labcorp's net margin of 6.99%. Hinge Health's return on equity of 51.60% beat Labcorp's return on equity. Company Net Margins Return on Equity Return on Assets Labcorp 6.99% 16.74% 7.81% Hinge Health 15.15% 51.60% 14.16%

Does the media favor LH or HNGE?

In the previous week, Hinge Health had 5 more articles in the media than Labcorp. MarketBeat recorded 10 mentions for Hinge Health and 5 mentions for Labcorp. Hinge Health's average media sentiment score of 0.55 beat Labcorp's score of 0.42 indicating that Hinge Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, GH or HNGE?

Guardant Health has higher revenue and earnings than Hinge Health. Guardant Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 23.33 -$416.28M -$3.49 N/A Hinge Health $587.86M 13.49 -$528.26M $1.28 76.78

Does the media prefer GH or HNGE?

In the previous week, Hinge Health had 6 more articles in the media than Guardant Health. MarketBeat recorded 10 mentions for Hinge Health and 4 mentions for Guardant Health. Hinge Health's average media sentiment score of 0.55 beat Guardant Health's score of 0.03 indicating that Hinge Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, HNGE or TEM?

Tempus AI has higher revenue and earnings than Hinge Health. Tempus AI is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hinge Health $587.86M 13.49 -$528.26M $1.28 76.78 Tempus AI $1.43B 9.07 -$245.03M -$1.44 N/A

Is HNGE or TEM more profitable?

Hinge Health has a net margin of 15.15% compared to Tempus AI's net margin of -17.77%. Hinge Health's return on equity of 51.60% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Hinge Health 15.15% 51.60% 14.16% Tempus AI -17.77% -50.28% -10.33%

Does the media refer more to HNGE or TEM?

In the previous week, Tempus AI had 1 more articles in the media than Hinge Health. MarketBeat recorded 11 mentions for Tempus AI and 10 mentions for Hinge Health. Tempus AI's average media sentiment score of 1.03 beat Hinge Health's score of 0.55 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 5 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HNGE or FMS?

In the previous week, Hinge Health had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for Hinge Health and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Hinge Health's average media sentiment score of 0.55 beat Fresenius Medical Care AG & Co. KGaA's score of 0.34 indicating that Hinge Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Hinge Health (HNGE) Competitors

$98.27 -0.08 (-0.08%)

Closing price 10/6/2026 03:59 PM Eastern

Extended Trading

$97.50 -0.77 (-0.79%)

As of 10/6/2026 07:57 PM Eastern

Compare

HNGE vs. DGX, LH, GH, TEM, and FMS

Should you buy Hinge Health stock or one of its competitors? Hinge Health's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Tempus AI (TEM), and Fresenius Medical Care AG & Co. KGaA (FMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hinge Health compare to Quest Diagnostics?

Hinge Health (NYSE:HNGE) and Quest Diagnostics (NYSE:DGX) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Hinge Health has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

In the previous week, Hinge Health had 3 more articles in the media than Quest Diagnostics. MarketBeat recorded 10 mentions for Hinge Health and 7 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 0.61 beat Hinge Health's score of 0.55 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quest Diagnostics	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health has a net margin of 15.15% compared to Quest Diagnostics' net margin of 9.18%. Hinge Health's return on equity of 51.60% beat Quest Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Quest Diagnostics	9.18%	16.01%	7.27%

Quest Diagnostics has higher revenue and earnings than Hinge Health. Quest Diagnostics is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78
Quest Diagnostics	$11.04B	2.28	$992M	$9.42	24.23

Hinge Health currently has a consensus target price of $105.33, indicating a potential upside of 7.19%. Quest Diagnostics has a consensus target price of $237.08, indicating a potential upside of 3.88%. Given Hinge Health's stronger consensus rating and higher probable upside, research analysts clearly believe Hinge Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

88.1% of Quest Diagnostics shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by insiders. Comparatively, 0.9% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Hinge Health beats Quest Diagnostics on 11 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Labcorp?

Labcorp (NYSE:LH) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Labcorp has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

Labcorp has higher revenue and earnings than Hinge Health. Labcorp is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.95B	1.81	$876.50M	$12.09	25.78
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78

95.9% of Labcorp shares are held by institutional investors. 0.8% of Labcorp shares are held by company insiders. Comparatively, 18.9% of Hinge Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Hinge Health had 5 more articles in the media than Labcorp. MarketBeat recorded 10 mentions for Hinge Health and 5 mentions for Labcorp. Hinge Health's average media sentiment score of 0.55 beat Labcorp's score of 0.42 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health has a net margin of 15.15% compared to Labcorp's net margin of 6.99%. Hinge Health's return on equity of 51.60% beat Labcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	6.99%	16.74%	7.81%
Hinge Health	15.15%	51.60%	14.16%

Labcorp currently has a consensus price target of $337.73, suggesting a potential upside of 8.34%. Hinge Health has a consensus price target of $105.33, suggesting a potential upside of 7.19%. Given Labcorp's higher possible upside, equities research analysts clearly believe Labcorp is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

Summary

Hinge Health beats Labcorp on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.

In the previous week, Hinge Health had 6 more articles in the media than Guardant Health. MarketBeat recorded 10 mentions for Hinge Health and 4 mentions for Guardant Health. Hinge Health's average media sentiment score of 0.55 beat Guardant Health's score of 0.03 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health has higher revenue and earnings than Hinge Health. Guardant Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	23.33	-$416.28M	-$3.49	N/A
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78

Hinge Health has a net margin of 15.15% compared to Guardant Health's net margin of -38.33%. Hinge Health's return on equity of 51.60% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Hinge Health	15.15%	51.60%	14.16%

Guardant Health has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

Guardant Health currently has a consensus target price of $188.54, suggesting a potential upside of 10.46%. Hinge Health has a consensus target price of $105.33, suggesting a potential upside of 7.19%. Given Guardant Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Guardant Health is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 18.9% of Hinge Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Guardant Health and Hinge Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Tempus AI?

Hinge Health (NYSE:HNGE) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

In the previous week, Tempus AI had 1 more articles in the media than Hinge Health. MarketBeat recorded 11 mentions for Tempus AI and 10 mentions for Hinge Health. Tempus AI's average media sentiment score of 1.03 beat Hinge Health's score of 0.55 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	5 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hinge Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.54, suggesting that its stock price is 254% more volatile than the broader market.

Hinge Health has a net margin of 15.15% compared to Tempus AI's net margin of -17.77%. Hinge Health's return on equity of 51.60% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Tempus AI	-17.77%	-50.28%	-10.33%

Tempus AI has higher revenue and earnings than Hinge Health. Tempus AI is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78
Tempus AI	$1.43B	9.07	-$245.03M	-$1.44	N/A

24.2% of Tempus AI shares are held by institutional investors. 18.9% of Hinge Health shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Hinge Health presently has a consensus target price of $105.33, suggesting a potential upside of 7.19%. Tempus AI has a consensus target price of $71.05, suggesting a potential downside of 1.29%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts clearly believe Hinge Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

Summary

Hinge Health beats Tempus AI on 10 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Fresenius Medical Care AG & Co. KGaA?

Hinge Health (NYSE:HNGE) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 18.9% of Hinge Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hinge Health has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Hinge Health currently has a consensus price target of $105.33, suggesting a potential upside of 7.19%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.68, suggesting a potential upside of 5.54%. Given Hinge Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Hinge Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

In the previous week, Hinge Health had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for Hinge Health and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Hinge Health's average media sentiment score of 0.55 beat Fresenius Medical Care AG & Co. KGaA's score of 0.34 indicating that Hinge Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hinge Health has a net margin of 15.15% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Hinge Health's return on equity of 51.60% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hinge Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	13.49	-$528.26M	$1.28	76.78
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.62

Summary

Hinge Health beats Fresenius Medical Care AG & Co. KGaA on 13 of the 17 factors compared between the two stocks.

Get Hinge Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HNGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HNGE vs. The Competition

Export

Metric	Hinge Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$7.94B	$9.84B	$7.19B	$22.91B
Dividend Yield	N/A	2.60%	2.53%	3.72%
P/E Ratio	76.78	33.83	273.37	28.11
Price / Sales	13.49	4.93	591.57	14.98
Price / Cash	N/A	118.45	79.41	36.95
Price / Book	43.48	5.14	11.04	4.72
Net Income	-$528.26M	$315.68M	$3.50B	$1.07B
7 Day Performance	0.78%	-0.77%	-2.06%	1.31%
1 Month Performance	6.59%	-2.90%	-7.05%	-4.97%
1 Year Performance	91.95%	9.94%	5.78%	6.66%

Hinge Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
HNGE Hinge Health	3.668 of 5 stars	$98.27 -0.1%	$105.33 +7.2%	+89.3%	$7.94B	$587.86M	76.78	1,437
DGX Quest Diagnostics	4.2757 of 5 stars	$237.60 +0.5%	$237.08 -0.2%	+27.8%	$26.22B	$11.04B	25.22	57,000
LH Labcorp	4.1506 of 5 stars	$309.85 +0.1%	$337.73 +9.0%	+13.2%	$25.13B	$13.95B	25.63	71,000
GH Guardant Health	2.2023 of 5 stars	$177.33 +0.0%	$188.13 +6.1%	+169.3%	$23.80B	$982.02M	N/A	2,506
TEM Tempus AI	1.9862 of 5 stars	$85.08 +0.1%	$69.63 -18.2%	-22.7%	$15.35B	$1.27B	N/A	3,800

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HNGE) was last updated on 10/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hinge Health (HNGE) Competitors

HNGE vs. DGX, LH, GH, TEM, and FMS

How does Hinge Health compare to Quest Diagnostics?

Summary

How does Hinge Health compare to Labcorp?

Summary

How does Hinge Health compare to Guardant Health?

Summary

How does Hinge Health compare to Tempus AI?

Summary

How does Hinge Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HNGE vs. The Competition

Hinge Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hinge Health (HNGE) Competitors

HNGE vs. DGX, LH, GH, TEM, and FMS

How does Hinge Health compare to Quest Diagnostics?

Which has more risk & volatility, HNGE or DGX?

Does the media refer more to HNGE or DGX?

Is HNGE or DGX more profitable?

Which has stronger earnings and valuation, HNGE or DGX?

Do analysts recommend HNGE or DGX?

Do insiders and institutionals believe in HNGE or DGX?

Summary

How does Hinge Health compare to Labcorp?

Which has more volatility & risk, LH or HNGE?

Which has stronger earnings and valuation, LH or HNGE?

Do insiders & institutionals hold more shares of LH or HNGE?

Does the media favor LH or HNGE?

Is LH or HNGE more profitable?

Do analysts prefer LH or HNGE?

Summary

How does Hinge Health compare to Guardant Health?

Does the media prefer GH or HNGE?

Which has preferable earnings and valuation, GH or HNGE?

Is GH or HNGE more profitable?

Which has more volatility and risk, GH or HNGE?

Do analysts prefer GH or HNGE?

Do insiders and institutionals hold more shares of GH or HNGE?

Summary

How does Hinge Health compare to Tempus AI?

Does the media refer more to HNGE or TEM?

Which has more volatility & risk, HNGE or TEM?

Is HNGE or TEM more profitable?

Which has preferable valuation & earnings, HNGE or TEM?

Do institutionals and insiders believe in HNGE or TEM?

Do analysts prefer HNGE or TEM?

Summary

How does Hinge Health compare to Fresenius Medical Care AG & Co. KGaA?

Do insiders and institutionals believe in HNGE or FMS?

Which has more volatility and risk, HNGE or FMS?

Do analysts prefer HNGE or FMS?

Does the media refer more to HNGE or FMS?

Is HNGE or FMS more profitable?

Which has stronger valuation and earnings, HNGE or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HNGE vs. The Competition

Hinge Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools